Business
CVS Stock Down On Early Warnings About 2027
CVS Health saw its shares dip about 6% even though it handily beat Wall Street’s expectations for the most recent quarter and raised its guidance for 2026 earnings. The issue was the company’s unusually early commentary about 2027.
The healthcare giant warned that membership in its Caremark pharmacy-benefits manager will decline next year, as it rewrites contracts to reflect a new pricing model and as some of its insurer clients pull back from certain markets. The warning comes amid broader investor concern about the evolving financial model of PBMs.
The company also flagged pressures related to the 340B drug-discount program. CVS offered a more upbeat view of continued improvements at Aetna, its insurance arm.
You must be logged in to post a comment Login